| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5007 | T6603185 | Novel inhibitor of the catalytic functions of peroxiredoxin (Prx) and thioredoxin (Trx) systems |
|
| DCC5008 | Tachioside | Natural radical scavenger on ABTS |
|
| DCC5009 | Tachyplegina | Novel Inhibitor of Parasite Motility and Invasion |
|
| DCC5010 | Tachyplegina-2 | Novel Inhibitor of Parasite Motility and Invasion |
|
| DCC5011 | Tachyplegina-4 | Novel Irriversible Inhibitor of Parasite Motility and Invasion |
|
| DCC5012 | Tacrine-pyrimidone Hybrid 27g | Novel Potent Dual AChE/GSK-3 Inhibitor for the Treatment of Alzheimers Disease |
|
| DCC5013 | Tah-19 | Novel potent p53-MDM2/X antagonist, inhibiting MDM2 potently with a Ki value of 58 nmol/L, inducing accumulation of p53, p21 and MDM2, inhibiting cell cycle progression of U-2 OS cells at G1 phase in a p53-dependent manner |
|
| DCC5014 | Ta-in-2 | Novel inhibitor of the Klebsiella pneumoniae VapBC toxin-antitoxin (TA) system, acting as antimicrobial agents by disrupting the VapBC complex and activating VapC |
|
| DCC5015 | Tak-137 | Novel AMPA receptor potentiator with little agonistic effect, producing antidepressant-like effect without causing psychotomimetic effects |
|
| DCC5016 | tak-187 | Long-lasting ergosterol biosynthesis inhibitor |
|
| DCC5017 | Tak-21d | Potent FAAH Inhibitor |
|
| DCC5018 | Tak-220 Hydrochloride | Novel anti-HIV CCR5 antagonist |
|
| DCC5019 | Tak-233 | Novel selective 5-hydroxytryptamine type 2C (5-HT2C) receptor agonist |
|
| DCC5020 | Tak-418 | Novel inhibitor of the epigenetic modulator lysine-specific demethylase 1A (LSD1) |
|
| DCC5021 | Talaroconvolutin A | Natural ferroptosis inducer, killing colorectal cancer cells in vitro and in vivo |
|
| DCC5022 | Talarozole | CYP26 inhibitor, potentiating the effects of all-trans retinoic acid on cultured human epidermal keratinocytes |
|
| DCC5023 | Talaumidin | Natural neurotrophic agent, promoting neurite outgrowth from neurons through PI3K/Akt pathway |
|
| DCC5024 | Talirine | Novel Antibody-Drug Conjugate PBD Dimer Payload |
|
| DCC5025 | Taltirelin | Superagonist at the human thyrotropin-releasing hormone receptor, reversing opioid-induced respiratory depression in isoflurane anesthetized rats |
|
| DCC5026 | Tamra-edatp | Novel Fluorescent dATP for DNA Synthesis In Vivo, exhibited high brightness, low toxicity, and rapid incorporation and depletion kinetics in both a vertebrate (zebrafish) and a nematode (Caenorhabditis elegans) |
|
| DCC5027 | Tan-67 | Potent and selective non-peptide δ1 opioid receptor agonist |
|
| DCC5028 | Tanshinol Borneol Ester | Novel angiogenesis stimulator, promoting multiple key steps of angiogenesis parially via Akt and MAPK signalling pathways, showing anti-ischemic and anti-atherosclerosis activities, also acting as a putative PPARγ agonist |
|
| DCC5029 | Tap1a-opt1 | Novel potent Na V -targeting peptide, exhibiting significant increased potency for Na V 1.1, Na V 1.2, Na V 1.3, Na V 1.6 and Na V 1.7 involved in several neurological disorders including acute and chronic pain, motor neuron disease and epilepsy |
|
| DCC5030 | Tap1a-opt2 | Novel potent Na V -targeting peptide, exhibiting significant increased potency for Na V 1.1, Na V 1.2, Na V 1.3, Na V 1.6 and Na V 1.7 involved in several neurological disorders including acute and chronic pain, motor neuron disease and epilepsy |
|
| DCC5031 | Tapi-2 Acetate | ADAM-17 (TACE) and MMP inhibitor, sensitizing cancer stem cells to the lethal effects of 5-FU and blocking shedding of TNF-α from cell membranes |
|
| DCC5032 | Tariquidar Dimesylate | Potent P-glycoprotein (P-gp) inhibitor |
|
| DCC5033 | Tas-303 Hydrochloride | Novel selective norepinephrine reuptake inhibitor, displaying significant norepinephrine transporter (NET) inhibitory activity toward the serotonin or dopamine transporters |
|
| DCC5034 | tasidotin Hydrochloride | Tubulin-binding dolastatin-15 analog, demostrating a wide spectrum of In Vivo antitumor activity |
|
| DCC5035 | Tasp0233278 | Potent and orally active V 1B receptor antagonist with antidepressant and anxiolytic activities in rodents |
|
| DCC5036 | Tasp0277308 | Potent and selective sphingosine 1-phosphate 1 (S1P1) receptor antagonist (IC50 = 7.8 nM) |
|
